Current Role of Anti-Integrin Therapy in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic inflammatory intestinal disorder with multifactorial etiology. Management of IBD is divided into conventional treatment and new treatment with biologic agents. The first biologic agents used for IBD was tumor necrosis factor (TNF)-inhibitor. However, TNF...

Full description

Bibliographic Details
Published in:	The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Main Authors:	Kevin Winston, Hasan Maulahela, Lusiani Lusiani, Raditya Dewangga, Lazuardi G Ilhami
Format:	Article
Language:	English
Published:	Interna Publishing 2020-09-01
Subjects:	anti-integrin inflammatory bowel disease (ibd) crohn’s disease (cd) ulcerative colitis (uc) leukocyte trafficking biological therapy
Online Access:	https://www.ina-jghe.com/index.php/jghe/article/view/743

Similar Items

A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia
by: Ahmed A. Al-Fawzan, et al.
Published: (2023-06-01)

Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study
by: Ingunn Johansen, et al.
Published: (2023-07-01)

Inflammatory bowel diseases in pregnant women - current state of knowledge
by: Karolina Góra, et al.
Published: (2023-04-01)

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
by: Kyeong-Ryoon Lee, et al.
Published: (2024-11-01)

Exploring Electrical Neuromodulation as an Alternative Therapeutic Approach in Inflammatory Bowel Diseases
by: Suofeiya Dilixiati, et al.
Published: (2024-04-01)

Investigating the Activity Status of Inflammatory Bowel Disease and its Related Factors: A Study Protocol
by: Mehrnaz Asgharnezhad, et al.
Published: (2025-01-01)

The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review
by: Nariman Hossein-Javaheri, et al.
Published: (2023-08-01)

Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients
by: Kaneschka Yaqubi, et al.
Published: (2024-03-01)

The Prokineticin System in Inflammatory Bowel Diseases: A Clinical and Preclinical Overview
by: Giada Amodeo, et al.
Published: (2023-11-01)

Association between Inflammatory Bowel Disease and Subsequent Development of Restless Legs Syndrome and Parkinson’s Disease: A Retrospective Cohort Study of 35,988 Primary Care Patients in Germany
by: Sven H. Loosen, et al.
Published: (2023-03-01)

Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy
by: Eden Mariam Jacob, et al.
Published: (2020-12-01)

Individuals with Inflammatory Bowel Disease Have an Altered Gut Microbiome Composition of Fungi and Protozoa
by: Gina L. Guzzo, et al.
Published: (2022-09-01)

Correlation Of Fut2 And Fut3 Gene Polymorphisms With Inflammatory Bowel Disease In Guangxi Zhuang Population
by: Lv X, et al.
Published: (2025-03-01)

Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina
by: Nermin Salkić, et al.
Published: (2024-04-01)

Cerebral vein sinus thrombosis, an unusual complication of inflammatory bowel disease
by: Ahmad Yehia, et al.
Published: (2025-09-01)

The Role of Vitamin D in the Pathomechanism of Inflammatory Bowel Disease (IBD) and its Therapeutic Implications - a literature review
by: Wiktoria Maria Tomaszewska, et al.
Published: (2025-01-01)

Precision Medicine in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2023-08-01)

Role of Hydrogen Sulfide in Inflammatory Bowel Disease
by: Nathalie Stummer, et al.
Published: (2023-08-01)

Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease
by: Éva Boros, et al.
Published: (2022-09-01)

Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan
by: Sima Besharat, et al.
Published: (2024-02-01)

A Review of Fecal Microbiota Transplantation in Children—Exploring Its Role in the Treatment of Inflammatory Bowel Diseases
by: Yanna Ko, et al.
Published: (2024-11-01)

Association between systemic lupus erythematosus and inflammatory bowel disease in European and East Asian populations: a two-sample Mendelian randomization study
by: Weidong Xie, et al.
Published: (2023-11-01)

STABILITY (Symptomatic Review during Biologic Therapy) of Inflammatory Bowel Disease Patients Receiving Infusion Therapy Improves Clinical Outcomes
by: Kelli Morgan, et al.
Published: (2024-08-01)

Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history
by: James Guoxian Huang, et al.
Published: (2020-06-01)

Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease
by: Aranzazu Jauregui-Amezaga, et al.
Published: (2021-06-01)

Atypical «overlapping» variants of inflammatory bowel diseases
by: Kh. M. Akhrieva, et al.
Published: (2024-10-01)

Characteristics of the Inflammatory Bowel Disease in Children: A Croatian Single-Centre Retrospective Study
by: Ivan Pivac, et al.
Published: (2023-10-01)

Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease
by: Andrea Costantino, et al.
Published: (2023-10-01)

VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDY
by: Ramir Luan PERIN, et al.

The impact of diet on the inflammatory bowel disease course – a literature review
by: Agnieszka Nowotarska, et al.
Published: (2024-11-01)

A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease
by: Yassin EL‐Najjar, et al.
Published: (2025-06-01)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
by: Tyler Atagozli, et al.
Published: (2023-04-01)

Evaluation of LncRNA uc.173 and Occludin in Iranian Patients with Inflammatory Bowel Disease Compared with Healthy Individuals
by: Vahid Chaleshi, et al.
Published: (2022-04-01)

Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models
by: Kanika Suri, et al.
Published: (2021-08-01)

Iron Deficiency Anemia in Inflammatory Bowel Disease
by: Izabela Dzikowska, et al.
Published: (2025-04-01)

Modern Strategies in the Pharmacotherapy of Inflammatory Bowel Diseases – A Literature Review
by: Bartłomiej Czarnecki, et al.
Published: (2025-07-01)

Inferencing Medical Knowledge from an Artificial Neural Network in Inflammatory Bowel Disease
by: Lidia NEAMȚI, et al.
Published: (2024-06-01)

Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania
by: Adrian Goldiș, et al.
Published: (2019-10-01)

Intestinal ultrasound for follow-up after 24 weeks of biological therapy in inflammatory bowel disease patients: an Egyptian center experience during the COVID-19 pandemic
by: Sarah El-Nakeep, et al.
Published: (2024-08-01)

Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta-analysis
by: Mahboube Ganji-Arjenaki, et al.
Published: (2017-07-01)